MYNEO THERAPEUTICS
A little history
myNEO Therapeutics was founded in 2018 by leading biotech entrepreneurs combining expertise from different academic institutions. Cedric Bogaert, Jan Van Den Berghe, and Wim van Criekinge have since then expanded the team with established domain in neoantigen discovery experts as well as ambitious talent to further grow the company’s innovation and developments.
To date, myNEO Therapeutics has achieved several pivotal milestones in realizing its vision.
These include:
- Development of state-of-the-art neoantigen prediction algorithms
- Discovery of novel, dark antigen targets called camyotopes
- (Co-)development of novel immunotherapeutics products via strategic collaborations or in-house
- The publication of high-impact scientific papers
- Securing valuable intellectual property with multiple patents
- Receiving several prestigious awards (Most Disruptive Innovator, Forbes 30under30, Rising Star Fast50)
THE TEAM
The people behind myNEO Therapeutics
Team
Board
Advisors
Innovating immunotherapies,
transforming tomorrow
Subscribe to our newsletter
Get the latest news & updates about myNEO Therapeutics
Home
About us
Products
Technology
Partners
Services
Contact
Quick links
Publications
Latest news
Privacy statement
Terms of use
Careers
Cookie statement
We use cookies to enhance your browsing experience and provide analytics. By continuing to use this website, you agree to our use of cookies. For more information, please read our privacy statement.
myNEO BV
Ottergemsesteenweg-Zuid 808 B511, 9000 Ghent, East-Flanders
Belgium (BE0715710837)
Design by
